# The impacts of government reimbursement negotiation on targeted anticancer medication price, volume and spending in China

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/the-impacts-of-government-reimbursement-negotiation-on-targeted-anticancer/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yichen Zhang,Haishaerjiang Wushouer,Sheng Han,Mengyuan Fu,Xiaodong Guan,Luwen Shi,Anita K. Wagner |
| Citations | 73 |
| DOI | 10.1136/bmjgh-2021-006196 |
| Fields | Economics, Econometrics and Finance |
| Open Access | true |
| OA Status | gold |
| OA URL | https://gh.bmj.com/content/bmjgh/6/7/e006196.full.pdf |
| OpenAlex ID | https://openalex.org/W3181146697 |
| PMID | 34266848 |
| Type | article |
| Year | 2021 |

## Paper authors

- [Sheng Han](https://scholariq.org/researchers/sheng-han/)

## Paper journal

- [BMJ Global Health](https://scholariq.org/journals/bmj-global-health/)

## Paper primary topic

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)

## Paper topics

- [Economic and Financial Impacts of Cancer](https://scholariq.org/topics/economic-and-financial-impacts-of-cancer/)
- [Pharmaceutical Economics and Policy](https://scholariq.org/topics/pharmaceutical-economics-and-policy/)
- [Health Systems, Economic Evaluations, Quality of Life](https://scholariq.org/topics/health-systems-economic-evaluations-quality-of-life/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.